BCHE and Alzheimer disease: The current clinical treatment drugs for AD are mainly cholinesterase inhibitors, including: donepezil, rivastigmine, galantamine; and the N-methyl-D-aspartic acid (NMDA) receptor antagonists: memantine and amantadine.